Fausto Sanchez-Munoz

Dr. Fausto Sanchez-Munoz

Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Ciudad de México, Mexico
orcid
Mentorship, Legacy & Passing the Torch

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz
ADAaron Dominguez-Lopez
Aaron Dominguez-Lopez
Jesus K. Yamamoto-FurushoJesus K. Yamamoto-Furusho
Jesus K. Yamamoto-Furusho
Role of cytokines in inflammatory bowel disease

1 October 2008 in Obesity
Verified
Journal Article
Open access
PDF file
MVMarisela Villalobos‐Comparán
Marisela Villalobos‐Comparán
MFM. Teresa Flores‐Dorantes
M. Teresa Flores‐Dorantes
MMMaria Teresa Villarreal Molina
Maria Teresa Villarreal Molina
MRMaricela Rodríguez‐Cruz
Maricela Rodríguez‐Cruz
AUAna Cristina García Ulloa
Ana Cristina García Ulloa
SCSamuel Canizales‐Quinteros
Samuel Canizales‐Quinteros
Common polymorphisms in the fat mass and obesity‐associated gene (FTO) have shown strong association with obesity in several populations. In the present study, we explored the association of FTO gene polymorphisms with obesity and other biochemical parameters in the Mexican population. We also assessed FTO gene expression levels in adipose tissue of obese and nonobese individuals. The study comprised 788 unrelated Mexican‐Mestizo individuals and 31 subcutaneous fat tissue biopsies from lean and obese women. FTO single‐nucleotide polymorphisms (SNPs) rs9939609, rs1421085, and rs17817449 were associated with obesity, particularly with class III obesity, under both additive and dominant models (P = 0.0000004 and 0.000008, respectively). These associations remained significant after adjusting for admixture (P = 0.000003 and 0.00009, respectively). Moreover, risk alleles showed a nominal association with lower insulin levels and homeostasis model assessment of B‐cell function (HOMA‐B), and with higher homeostasis model assessment of insulin sensitivity (HOMA‐S) only in nonobese individuals (P dom = 0.031, 0.023, and 0.049, respectively). FTO mRNA levels were significantly higher in subcutaneous fat tissue of class III obese individuals than in lean individuals (P = 0.043). Risk alleles were significantly associated with higher FTO expression in the class III obesity group (P = 0.047). In conclusion, FTO is a major risk factor for obesity (particularly class III) in the Mexican‐Mestizo population, and is upregulated in subcutaneous fat tissue of obese individuals.

Verified
Journal Article
Open access
PDF file
KCKARLA AIDEE AGUAYO CERON
KARLA AIDEE AGUAYO CERON
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz
RGRocío Alejandra Gutiérrez-Rojas
Rocío Alejandra Gutiérrez-Rojas
LALourdes Nallely Acevedo-Villavicencio
Lourdes Nallely Acevedo-Villavicencio
AFAurora Vanessa Flores-Zarate
Aurora Vanessa Flores-Zarate
RRRodrigo Romero-Nava
Rodrigo Romero-Nava
Glycine is a non-essential amino acid with many functions and effects. Glycine can bind to specific receptors and transporters that are expressed in many types of cells throughout an organism to exert its effects. There have been many studies focused on the anti-inflammatory effects of glycine, including its abilities to decrease pro-inflammatory cytokines and the concentration of free fatty acids, to improve the insulin response, and to mediate other changes. However, the mechanism through which glycine acts is not clear. In this review, we emphasize that glycine exerts its anti-inflammatory effects throughout the modulation of the expression of nuclear factor kappa B (NF-κB) in many cells. Although glycine is a non-essential amino acid, we highlight how dietary glycine supplementation is important in avoiding the development of chronic inflammation.

5 December 2017 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
BLBlanca Estela López-Contreras
Blanca Estela López-Contreras
SMS. Morán‐Ramos
S. Morán‐Ramos
RVR. Villarruel‐Vázquez
R. Villarruel‐Vázquez
LMLuis Rodrigo Macias
Luis Rodrigo Macias
HVH. Villamil‐Ramírez
H. Villamil‐Ramírez
SCSamuel Canizales-Quinteros
Samuel Canizales-Quinteros

1 May 2021 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
LALuis M Amezcua-Guerra
Luis M Amezcua-Guerra
GRGustavo Rojas-Velasco
Gustavo Rojas-Velasco
MBMalinalli Brianza-Padilla
Malinalli Brianza-Padilla
AVArmando Vázquez-Rangel
Armando Vázquez-Rangel
RMRicardo Márquez-Velasco
Ricardo Márquez-Velasco
MHMarisol Hernández-Salas
Marisol Hernández-Salas

Verified
Journal Article
Open access
PDF file
MHMohammed El Hafidi
Mohammed El Hafidi
Mabel Buelna-ChontalMabel Buelna-Chontal
Mabel Buelna-Chontal
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz
Roxana CarboRoxana Carbo
Roxana Carbo
Obesity is considered to significantly increase the risk of the development of a vast range of metabolic diseases. However, adipogenesis is a complex physiological process, necessary to sequester lipids effectively to avoid lipotoxicity in other tissues, like the liver, heart, muscle, essential for maintaining metabolic homeostasis and has a crucial role as a component of the innate immune system, far beyond than only being an inert mass of energy storage. In pathophysiological conditions, adipogenesis promotes a pro-inflammatory state, angiogenesis and the release of adipokines, which become dangerous to health. It results in a hypoxic state, causing oxidative stress and the synthesis and release of harmful free fatty acids. In this review, we try to explain the mechanisms occurring at the breaking point, at which adipogenesis leads to an uncontrolled lipotoxicity. This review highlights the types of adipose tissue and their functions, their way of storing lipids until a critical point, which is associated with hypoxia, inflammation, insulin resistance as well as lipodystrophy and adipogenesis modulation by Krüppel-like factors and miRNAs.